ADC Therapeutics (ADCT) Net Equity Issued and Repurchased (2024 - 2026)
ADC Therapeutics (ADCT) posted quarterly Net Equity Issued and Repurchased of -$20000.0 for Q1 2026, down 100.05% on a QoQ basis from $43.5 million in Q4 2025.
ADC Therapeutics (ADCT) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Net Equity Issued and Repurchased for 3 consecutive years, with -$20000.0 the latest figure, recorded in Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.7 million (up 7180.9% YoY) and the FY2025 annual result came in at $86.3 million, up 42.6% from the prior year.
- Net Equity Issued and Repurchased declined to -$20000.0 in Q1 2026 per ADCT's latest filing, from $43.5 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for ADCT reached as high as $43.5 million in Q4 2025 and fell as low as -$1.2 million in Q3 2024.
- A 3-year average of $21.4 million and a median of $21.6 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | -20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | 43.52 Mn |
| Dec 31, 2025 | 43.52 Mn |
| Jun 30, 2025 | 43.24 Mn |
| Jun 30, 2025 | 43.24 Mn |
| Sep 30, 2024 | -1.23 Mn |
| Sep 30, 2024 | -1.23 Mn |